COVID-19 ushered in a fundamental change in how medicine is being delivered.
To achieve success in this market, device manufacturers should consider working with providers to help contain costs and enhance outcomes.
All industries under the healthcare umbrella should embrace each other’s capabilities because no single category of player can master it and bring to consumers all that we need and demand, says Stephen Bernstein of McDermott Will & Emery.
With everything to gain, telehealth may lead to a new standard in health/wellness treatment while at the same time unifying the entire healthcare ecosystem.
In a Q&A with Zipnosis, Catherine Murphy explains the uptick in telehealth visits and how it is changing the continuum of care.
Personalized medicine is the future of healthcare, and artificial intelligence will play a big role.
The adoption of accurate non-invasive measures of liver health at the point of care is critical.
What you need to learn before thinking about seeking Medicare reimbursement for a clinical trial.
This year’s work plan includes several items that will impact medical device manufacturer and suppliers.
Billing in clinical trials has changed recently, so here is a summary of where it has been and where it is heading.